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Severe 
Leptospirosis 
Similar to 
Pandemic (H1N1) 
2009, Florida and 
Missouri, USA
To the Editor: Leptospirosis is 
caused by pathogenic spirochetes of 
the genus Leptospira and transmitted 
through direct contact of skin or 
mucous membranes with urine 
or tissues of Leptospira-infected 
animals or through indirect contact 
with contaminated freshwater or soil. 
Leptospirosis shares common clinical 
signs with inﬂ  uenza, including fever, 
headache, myalgia, and sometimes 
cough and gastrointestinal symptoms. 
During 2009, acute complicated 
inﬂ  uenza-like illness (ILI) and rapid 
progressive pneumonia were often 
attributed to pandemic (H1N1) 2009; 
however, alternative ﬁ  nal  diagnoses 
were reported to be common (1). We 
report 3 cases of severe leptospirosis 
in Florida and Missouri with clinical 
signs similar to those of pandemic 
(H1N1) 2009.
Patient 1 was a 40-year-old 
Florida man who sought treatment at 
an emergency department after a 4-day 
history of fever, myalgia, calf pain, 
malaise, and headache in July 2009. 
ILI was diagnosed. Laboratory testing 
was not performed, and the patient 
was instructed to take ibuprofen. 
Three days later, jaundice developed. 
He was admitted to an intensive-care 
unit with a diagnosis of hepatitis and 
acute renal failure. The man raised 
horses, goats, and chickens on his 
farm and was frequently employed to 
control rat infestations at an auto parts 
store and warehouse. Leptospirosis 
was suspected. Doxycycline was 
administered, and the man recovered 
and was discharged on the eighth 
day of hospitalization. Leptospira-
speciﬁ   c immunoglobulin M 
antibodies were detected by dot blot 
(ARUP Laboratories, Salt Lake City, 
Utah, USA) on the second of paired 
consecutive blood specimens.
Patient 2 was a 17-year-old 
Missouri woman with a history of 
obesity. She was hospitalized in 
August 2009 with a 5-day history of 
fever, myalgia, calf pain, malaise, 
headache, nausea, vomiting, dyspnea, 
and cough, complicated by acute renal 
failure. The diagnosis on admission 
was viral infection. On the third day 
of hospitalization, severe pneumonia 
and respiratory failure developed, and 
she was administered vancomycin, 
piperacillin/tazobactam, levoﬂ  oxacin, 
and doxycycline. She died the same 
day. Ten days before illness onset, 
she had swum in a creek near her 
residence.
Patient 3 was a 59-year-old 
Florida man with a history of obesity 
and diabetes mellitus. He sought 
treatment at a clinic in September 
2009 and reported a 5-day history 
of fever, myalgia, malaise, nausea, 
abdominal pain, and dyspnea. He was 
treated for gastritis. Two days later, 
he came to an emergency department 
and was admitted to the hospital with 
severe pneumonia and multiorgan 
failure; he died the next day. The man 
had frequently engaged in activities 
to control rat infestations on the farm 
where he raised chickens, pigs, and 
goats.
Although patients 2 and 3 were 
neither tested nor treated for inﬂ  uenza 
before they died, their clinical signs and 
rapidity of death prompted postmortem 
suspicion of pandemic (H1N1) 
2009. Autopsies were performed 
and formalin-ﬁ   xed tissues were 
submitted to the Centers for Disease 
Control and Prevention (Atlanta, GA, 
USA). Histopathologic evaluation 
of both patients demonstrated 
extensive pulmonary hemorrhage and 
interstitial nephritis (Figure, panels 
A and B), features consistent with 
leptospirosis. Immunohistochemical 
tests for leptospirosis, spotted fever 
group rickettsiae, and inﬂ  uenza  A 
were performed on multiple tissues 
obtained from patients 2 and 3. 
Immunohistochemical evidence of 
leptospiral infection was identiﬁ  ed in 
lung, liver, kidney, heart, and spleen 
tissue in both patients (Figure, panels 
C and D). 
These cases of severe lepto-
spirosis were reported during the 
2009 inﬂ  uenza  pandemic.  Although 
pulmonary hemorrhage (experienced 
by patients 2 and 3) is increasingly 
recognized as a severe manifestation 
of leptospirosis (2), it is also a known 
complication of inﬂ  uenza  (3). ILI 
was initially diagnosed in patient 
1, but symptom progression and 
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Figure. Photomicrographs of lung, liver, and kidney sections from patient 2 during study, Missouri and Florida, USA, 2009. Hematoxylin 
and eosin stain showed pulmonary hemorrhage (A) (original magniﬁ  cation ×10) and interstitial nephritis (B) (original magniﬁ  cation ×5), 2 
characteristic pathologic ﬁ  ndings of leptospirosis. Immunohistochemical testing showed scattered granular leptospiral antigens in liver (C) 
and kidney (D) (original magniﬁ  cation ×63). A color version of this ﬁ  gure is available online (www.cdc.gov/EID/content/17/6/1145-F.htm).LETTERS
clinical complications, combined 
with a history of animal exposure, 
prompted the physician to consider 
leptospirosis and to initiate appropriate 
antimicrobial drug therapy.
Autopsies are critical in 
determining the reasons for death 
after undiagnosed illness. Pulmonary 
involvement in cases of leptospirosis 
is characterized by congestion 
and hemorrhage, usually without 
prominent inﬂ  ammatory  inﬁ  ltrates 
(4); pulmonary involvement in cases 
of severe pandemic (H1N1) 2009 
typically manifests as diffuse alveolar 
damage (5). Postmortem diagnosis 
of leptospirosis was supported by 
characteristic histopathologic ﬁ  ndings, 
including pulmonary hemorrhage 
and interstitial nephritis, and was 
conﬁ   rmed by immunohistochemical 
tests. Our report illustrates the need 
for autopsies in unexpected deaths, 
even if the cause appears obvious in a 
speciﬁ  c clinical and epidemic setting.
Leptospirosis ceased being na-
tionally notiﬁ  able in the United States 
in 1994 and is likely underdiagnosed 
because it is not routinely considered 
in differential diagnoses. However, 
outbreaks with exposures similar to 
the case-patients we studied have been 
periodically reported in the United 
States (6–8). Because leptospirosis 
commonly manifests as acute febrile 
illness, cases can be underrecognized 
during infectious-disease epidemics 
(e.g., dengue) (9). Leptospirosis 
should be included in the differential 
diagnosis of acute febrile illness in the 
United States and other industrialized 
countries. Epidemiologic clues include 
recreational or occupational water 
exposure; animal exposure (including 
rodents) in the home or the workplace, 
travel to tropical areas, and water 
exposure during travel. These risk 
factors for leptospirosis are increasing 
in industrialized countries (10). 
Thorough patient-history reviews and 
consideration of alternative diagnoses 
are needed for cases of respiratory 
illness during an inﬂ  uenza pandemic.
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